Tag: AHA 2020
AHA 2020: Active AF screening associated with significant improvement in clinical...
Three-year clinical outcomes of the mHealth Screening to Prevent Strokes—mSToPS—study evaluating silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using Zio, the...
AHA 2020: AF detected more often in high risk patients recovering...
Atrial fibrillation (AF) was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac...
AHA 2020: Rivaroxaban may be comparable to warfarin for bioprosthetic mitral...
The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart disease and Atrial Fibrillation—show that rivaroxaban is comparable to warfarin for patients with bioprosthetic...